Bovine CA199 antibody and antigen (recombinant protein)
Diagnostic anti-Bovine CA199 antibodies pairs and antigen for animal health (animal Bovines/Cattle pancreatic and biliary tract tumors) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-BOV-CA199-Ag01 | Recombinant Bovine CA199 protein | 3090 |
GMP-BOV-CA199-Ab01 | Anti-Bovine CA199 mouse monoclonal antibody (mAb) | 1953 |
GMP-BOV-CA199-Ab02 | Anti-Bovine CA199 mouse monoclonal antibody (mAb) | 1953 |
GMP-BOV-CA199-Ab03 | Anti-Bovine CA199 human monoclonal antibody (mAb) | 1953 |
GMP-BOV-CA199-Ab04 | Anti-Bovine CA199 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-BOV-CA199-Ag01 |
Product Name | Recombinant Bovine CA199 protein |
Target/Biomarker | Bovine Carbohydrate antigen 19-9 (AIV-A H7N9 subtype) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Bovine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A H7N9 subtype level test of animal Bovines/Cattle with pancreatic and biliary tract tumors. |
Tag | His |
Products description | Recombinant Bovine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-BOV-CA199-Ab01, GMP-BOV-CA199-Ab02 |
Product Name | Anti-Bovine CA199 mouse monoclonal antibody (mAb) |
Target/Biomarker | Bovine Carbohydrate antigen 19-9 (AIV-A H7N9 subtype) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Bovine Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N9 subtype antibodies in AIV-A H7N9 subtype level test of animal Bovines/Cattle with pancreatic and biliary tract tumors. |
Tag | mFc |
Products description | Anti-Bovine CA199 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N9 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-BOV-CA199-Ab03, GMP-BOV-CA199-Ab04 |
Product Name | Anti-Bovine CA199 human monoclonal antibody (mAb) |
Target/Biomarker | Bovine Carbohydrate antigen 19-9 (AIV-A H7N9 subtype) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Bovine Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N9 subtype antibodies in AIV-A H7N9 subtype level test of animal Bovines/Cattle with pancreatic and biliary tract tumors. |
Tag | hFc |
Products description | Anti-Bovine CA199 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A H7N9 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in bovine (cattle) health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in cattle, including those affecting the gastrointestinal tract and pancreas. Structurally, CA199 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of bovine health, CA199 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal tract and pancreas can be insidious, often presenting with subtle or nonspecific clinical signs. CA199 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes. CA199 levels in a bovine's bloodstream become elevated when cancer cells, particularly those found in gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA199 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.